Pharma Mar, S.A.
PHMMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $11,985 | $1,137 | $43,790 | $95,129 |
| Dep. & Amort. | $6,773 | $5,756 | $5,900 | $5,583 |
| Deferred Tax | $0 | $0 | $0 | -$16,783 |
| Stock-Based Comp. | $0 | $297 | $393 | $339 |
| Change in WC | -$31,746 | -$34,923 | -$28,220 | -$61,408 |
| Other Non-Cash | $19,015 | $14,287 | $16,458 | $2,817 |
| Operating Cash Flow | $6,027 | -$13,446 | $38,321 | $25,677 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$15,015 | -$15,956 | -$8,852 | -$7,803 |
| Net Acquisitions | $0 | $0 | $11 | $0 |
| Inv. Purchases | -$351,475 | -$314,328 | -$219,199 | $0 |
| Inv. Sales/Matur. | $367,130 | $287,236 | $238,918 | $26,275 |
| Other Inv. Act. | $393 | $0 | $0 | $0 |
| Investing Cash Flow | $1,033 | -$43,048 | $10,878 | $18,472 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $8,908 | -$1,153 | -$8,658 | -$9,438 |
| Stock Issued | $18,911 | $18,606 | $57,227 | $33,554 |
| Stock Repurch. | -$18,696 | -$37,901 | -$50,178 | -$40,659 |
| Dividends Paid | -$11,420 | -$11,689 | -$11,761 | -$10,872 |
| Other Fin. Act. | -$3,053 | $0 | $0 | $0 |
| Financing Cash Flow | -$5,350 | -$32,137 | -$13,370 | -$27,415 |
| Forex Effect | $1,505 | -$1,158 | $636 | $404 |
| Net Chg. in Cash | $3,215 | -$89,789 | $36,465 | $17,138 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $60,024 | $149,813 | $113,348 | $96,210 |
| End Cash | $63,239 | $60,024 | $149,813 | $113,348 |
| Free Cash Flow | -$9,483 | -$29,402 | $29,469 | $17,874 |